The Angiogenic Activity of Ascites in the Course of Ovarian Cancer as a Marker of Disease Progression

被引:12
|
作者
Gawrychowski, Krzysztof [1 ]
Szewczyk, Grzegorz [2 ,3 ]
Skopinska-Rozewska, Ewa [4 ]
Malecki, Maciej [5 ,6 ]
Barcz, Ewa [7 ]
Kaminski, Pawel [7 ]
Miedzinska-Maciejewska, Magdalena [8 ]
Smiertka, Waclaw [9 ]
Szukiewicz, Dariusz [3 ]
Skopinski, Piotr [10 ]
机构
[1] Medicover Hosp, Dept Gynecol Oncol & Oncol, PL-02972 Warsaw, Poland
[2] Inst Mother & Child Hlth, Dept Obstet & Gynecol, PL-01211 Warsaw, Poland
[3] Med Univ Warsaw, Dept Gen & Expt Pathol, PL-02106 Warsaw, Poland
[4] Med Univ Warsaw, Ctr Biostruct Res, Dept Pathol, PL-02004 Warsaw, Poland
[5] Med Univ Warsaw, Dept Appl Pharm & Bioengn, Warsaw, Poland
[6] Inst Mother & Child Hlth, PL-01211 Warsaw, Poland
[7] Med Univ Warsaw, Dept Obstet & Gynecol 1, PL-02015 Warsaw, Poland
[8] Holy Family Hosp, Dept Surg Oncol, PL-02544 Warsaw, Poland
[9] Natl Inst Oncol, Dept Oncol, PL-02034 Warsaw, Poland
[10] Med Univ Warsaw, Ctr Biostruct Res, Dept Histol & Embryol, PL-02004 Warsaw, Poland
关键词
VASCULAR-PERMEABILITY FACTOR; EPITHELIAL OVARIAN; GROWTH; INTERLEUKIN-8; BEVACIZUMAB; TRIAL; CELLS;
D O I
10.1155/2014/683757
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ovarian cancer cells are able to create invasive implants in the peritoneum and their growth is directly associated with the angiogenetic potential. This effect is probably stimulated by vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8), which are both found in ascites. The aim of this study was to assess the influence of ascites produced by ovarian cancer on the angiogenesis. Peritoneal fluid was collected from patients with advanced ovarian cancer; cancer cells were separated from CD45+ leukocytes. Angiogenesis was assessed in mice, after intradermal injection of full cellular suspension together with supernatant or phosphate buffered saline, purified cancer cells suspension, or CD45+ leukocytes suspension. The angiogenesis index (AI) was assessed after 72 hours. VEGF and Il-8 were measured in the supernatant and cellular suspension. AI was the highest in the isolated cancer cells suspensions as well in the group stimulated with supernatant. Both VEGF and IL-8 were high in supernatants from ascites rich in cancer cells (>45%). A significant correlation was revealed between IL-8 concentration and AI. We conclude that ascites in patients with advanced ovarian cancer stimulates angiogenesis and this mechanism is dependent mostly on cancer cells activity and enhanced by cooperation with infiltrating leukocytes.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer
    Wellman, Theresa L.
    Eckenstein, Midori
    Wong, Cheung
    Rincon, Mercedes
    Ashikaga, Takamaru
    Mount, Sharon L.
    Francklyn, Christopher S.
    Lounsbury, Karen M.
    BMC CANCER, 2014, 14
  • [32] ACQUISITION OF ANGIOGENIC CAPACITY AS A MARKER OF PROGRESSION TOWARDS NEOPLASTIC TRANSFORMATION
    GULLINO, PM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (09): : 1286 - 1286
  • [33] IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
    Lo, Chi-Wen
    Chen, Min-Wei
    Hsiao, Michael
    Wang, Shiuan
    Chen, Chi-An
    Hsiao, Sheng-Mou
    Chang, Jeng-Shou
    Lai, Tsung-Ching
    Rose-John, Stefan
    Kuo, Min-Liang
    Wei, Lin-Hung
    CANCER RESEARCH, 2011, 71 (02) : 424 - 434
  • [34] IMPORTANCE OF ASCITES IN OVARIAN CANCER PATIENTS
    Baert, T.
    D'heygere, V.
    Laenen, A.
    Vandecaveye, V.
    Timmerman, D.
    Vergote, I.
    Coosemans, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 629 - 629
  • [35] WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer
    Kotrbova, Anna
    Ovesna, Petra
    Gybel, Tomas
    Radaszkiewicz, Tomasz
    Bednarikova, Marketa
    Hausnerova, Jitka
    Jandakova, Eva
    Minar, Lubos
    Crha, Igor
    Weinberger, Vit
    Zavesky, Ludek
    Bryja, Vitezslav
    Pospichalova, Vendula
    THERANOSTICS, 2020, 10 (02): : 537 - 552
  • [36] Ascites Volumes and the Ovarian Cancer Microenvironment
    Penet, Marie-France
    Krishnamachary, Balaji
    Wildes, Flonne B.
    Mironchik, Yelena
    Hung, Chien-Fu
    Wu, T. C.
    Bhujwalla, Zaver M.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [37] Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
    Carmi, Yifat Koren
    Agbarya, Abed
    Khamaisi, Hazem
    Farah, Raymond
    Shechtman, Yelena
    Korobochka, Roman
    Gopas, Jacob
    Mahajna, Jamal
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [38] Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers
    Kuk, Cynthia
    Kulasingam, Vathany
    Gunawardana, C. Geeth
    Smith, Chris R.
    Batruch, Ihor
    Diamandis, Eleftherios P.
    MOLECULAR & CELLULAR PROTEOMICS, 2009, 8 (04) : 661 - 669
  • [39] The bright side of ascites in ovarian cancer
    Cohen, Marie
    Petignat, Patrick
    CELL CYCLE, 2014, 13 (15) : 2319 - 2319
  • [40] CANCER: AN ANGIOGENIC DISEASE?
    Neeman, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 59 - 59